Sung-Sun Cho
Directeur Général chez YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD.
Profil
Sung-Sun Cho is currently the Chief Executive Officer and Director at Yuanta 4 SPECIAL PURPOSE ACQUISITION Co., Ltd.
Prior to this, Mr. Cho was the Chief Executive Officer at ProCell Therapeutics, Inc.
Postes actifs de Sung-Sun Cho
| Sociétés | Poste | Début |
|---|---|---|
| YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD. | Directeur Général | - |
Anciens postes connus de Sung-Sun Cho
| Sociétés | Poste | Fin |
|---|---|---|
ProCell Therapeutics, Inc.
 ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD. | Finance |
| Entreprise privées | 1 |
|---|---|
ProCell Therapeutics, Inc.
ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Health Technology |
